Impact of select actionable genomic alterations on efficacy of neoadjuvant immunotherapy in resectable non-small cell lung cancer.

Saved in:
Bibliographic Details
Title: Impact of select actionable genomic alterations on efficacy of neoadjuvant immunotherapy in resectable non-small cell lung cancer.
Authors: Zhou N; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Leung CH; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., William WN Jr; Department of Thoracic and Head and Neck Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA TCascone@MDAnderson.org william.william@medicos.oncoclinicas.com.; Grupo Oncoclínicas, Sao Paulo, Brazil., Weissferdt A; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Pataer A; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Godoy MCB; Department of Thoracic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Carter BW; Department of Thoracic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Fossella FV; Department of Thoracic and Head and Neck Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Tsao AS; Department of Thoracic and Head and Neck Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Blumenschein GR; Department of Thoracic and Head and Neck Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Le X; Department of Thoracic and Head and Neck Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Zhang J; Department of Thoracic and Head and Neck Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Skoulidis F; Department of Thoracic and Head and Neck Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kurie JM; Department of Thoracic and Head and Neck Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Altan M; Department of Thoracic and Head and Neck Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lu C; Department of Thoracic and Head and Neck Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Glisson BS; Department of Thoracic and Head and Neck Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Byers LA; Department of Thoracic and Head and Neck Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Elamin YY; Department of Thoracic and Head and Neck Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Mehran RJ; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Rice DC; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Walsh GL; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hofstetter WL; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Roth JA; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Tran HT; Department of Thoracic and Head and Neck Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Wu J; Department of Thoracic and Head and Neck Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Solis Soto LM; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kadara H; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Swisher SG; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Vaporciyan AA; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Gibbons DL; Department of Thoracic and Head and Neck Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lin HY; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lee JJ; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Heymach JV; Department of Thoracic and Head and Neck Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Negrao MV; Department of Thoracic and Head and Neck Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Sepesi B; Sarah Cannon Cancer Institute, Swedish Medical Center, Englewood, Colorado, USA., Cascone T; Department of Thoracic and Head and Neck Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA TCascone@MDAnderson.org william.william@medicos.oncoclinicas.com.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Oct 23; Vol. 12 (10). Date of Electronic Publication: 2024 Oct 23.
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2051-1426
DOI:10.1136/jitc-2024-009677